Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeting Investigation and Treatment in Patients With Type 2 Myocardial Infarction (TARGET-Type 2): A Pilot Randomised Controlled Trial

NCT05419583 is registered in ClinicalTrials.gov with University of Edinburgh as lead sponsor.

NCT NCT05419583
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05419583 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeting Investigation and Treatment in Patients With Type 2 Myocardial Infarction (TARGET-Type 2): A Pilot Randomised Controlled Trial
Lead sponsor
University of Edinburgh
Phase
Not applicable
Overall status
Completed
Start date
November 14, 2022
Completion date
June 30, 2024
Enrollment
60 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

myocardial infarction type 2